Incretin-Based Drugs Market Boosting Revenue Size in Pharma Industry: GlaxoSmithKline, Johnson & Johnson, Merck , AstraZeneca and More
The companies profiled in the report include, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., AstraZeneca plc, Novartis AG, Eli Lilly and Company, Boehringer Ingelheim GmbH, Takeda Pharmaceutical Company Ltd and Sanofi S.A.
Get Sample PDF Brochure of Incretin-Based Drugs Market Study at : https://www.alliedmarketresearch.com/request-toc-and-sample/657
This has resulted in a strong need for better therapeutics such as incretin based drugs. Incretin not only increases the secretion of insulin by acting on pancreatic beta cells, but also inhibits the release of glucagon by acting on the pancreatic alpha cells. Incretin based drugs namely; Incretin mimetics (GLP-1 agonist) and DPP-4 inhibitors work on the antidiabetic principle of incretin hormone.
Incretin based drugs reduce body weight and have better cardiovascular outcomes. The major drivers of global incretin based drugs market are increasing incidence of diabetes, rising old age population, increasing rate of cardiovascular diseases and obesity, sedentary lifestyle and increasing awareness of diabetes. Furthermore, large number of either undiagnosed or pre-diabetic patients across the globe, could further fuel the market growth. However, high cost of treatment, lack of reimbursement, poor accessibility to drugs especially in developing countries, and some safety concerns associated with incretin based drugs, are likely to restrain the market.
The global incretin-based drugs market is segmented on the basis of drug type, formulation, and geography. On the basis of drug type, market is further segmented into Glucagon-like peptide-1 receptor (GLP-1) agonists and Dipeptidyl Peptidase-4 (DPP-4) inhibitors. According to formulation, the market is segmented into oral and injectable drugs. Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific and LAMEA.
New product launches and approvals are the few strategies adopted by top industry players. Recently GlaxoSmithKline has launched subcutaneous injection of Tanzeum (albiglutide), a GLP-1 agonist for treatment for type 2 diabetes. In March 2015, Takeda Pharmaceutical got Japanese approval for oral tablet Zafatek, a DPP-4 inhibitor.
Key Market Benefits:
• Comprehensive analysis of factors that drive and restrict the growth of the global incretin-based drugs market is provided
• The market estimations are made in the report by conducting high-end analysis of the key market segments for the period of 2014‐2020, which would enable the stakeholders to capitalize on prevailing market opportunities
• An in-depth analysis of key segments of the market demonstrates the types of drugs and formulations that are currently being used along with the variants that would gain prominence in future
• SWOT analysis enables to study the internal environment of the leading companies for strategy formulation
• Region-wise incretin-based drugs market conditions are comprehensively analyzed in the report
Do Purchase Enquiry at : https://www.alliedmarketresearch.com/purchase-enquiry/657
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Incretin-Based Drugs Market Boosting Revenue Size in Pharma Industry: GlaxoSmithKline, Johnson & Johnson, Merck , AstraZeneca and More here
News-ID: 1537497 • Views: 500
More Releases from Allied Market Research
Tile Grout and Adhesives Market Industry Size & Share, Trends, Demand, Growth Op …
Rise in adoption of thermally treated tiles, growing popularity of outdoor entertaining area among residential end users, and surge in residential and non-residential construction activities drive the growth of the tile grout and adhesives market. However, threat of substitute products and fluctuations in foreign currencies may hamper the tile grout and adhesives market growth. Furthermore, increase in emphasis toward utilization of low VOC grout and adhesive is expected to offer
Connected Aircraft Market Top Manufacturers, Product Types, Sales and Demand 202 …
The revolution has arrived in aviation industry in the form of connected aircrafts. Connected aircraft helps in improving fleet management, airline operations, aircraft turnaround time, flight safety, passenger experience, and costs. Connected aircraft concept allows the airline passengers to surf the internet at 30000 feet. Moreover, the concept of connected aircraft may boost the operational efficiency of the aircraft and can also improve communications, navigation, and surveillance (CNS) for air
Stacker Market Professional Survey 2021 by Manufacturers, Share, Growth, Trends, …
Based on type, the electric segment accrued the largest share in the stacker market. Expansion of the construction and logistics industry throughout the globe, especially in emerging nations such as China and India drives the stacker market growth. Moreover, stacker is suited for heavy tasks, owing to their features such as high load capacity, versatility, and flexibility. Thus, such advantageous features are expected to fuel the demand for stacker market
Industrial Lasers Systems Market Based on Current and Future Trends, Development …
By type, the macro processing segment accrued the largest share in the industrial lasers systems market in 2018. Growth in demand for lasers in industrial applications such as additive manufacturing, marking, cutting, and welding fuels the demand for lasers for macro processing applications. In addition, expansion of the automotive and metal cutting industry throughout the globe, especially in emerging nations such as China and India drives the industrial lasers
More Releases for Incretin
Global Incretin-Based Drugs Market 2020 Business Strategies – Boehringer Ingel …
The market report titled “Incretin-Based Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024” and published by Zion Market Research will put forth a systematizedevaluation of the vital facets of the global Incretin-Based Drugs market. The report willfunction as a medium for the better assessment of the existing and future situations of the global market. It will be offering a 360-degree framework of the competitive landscape and
Incretin-Based Drugs Market Detailed Report With Growth Opportunity by Major Pla …
Up Market Research published a detailed report on “Incretin-Based Drugs Market”. The report provides an in-depth overview of industry and competitive landscape, covering multiple market segments and elaborates market outlook and status to 2026. Get Sample Copy Of This Report @ https://www.upmarketresearch.com/home/requested_sample/60908 The report contains 92 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Incretin-Based Drugs Market research report delivers
Incretin-based Drugs Market Size & Share by Application, Type and Region - Globa …
MarketResearchReports.Biz is providing you Retail Market Research report of "Incretin-based Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025". The main objective of this report is to define, describe, and forecast the global “Incretin-based Drugs” market on the basis of types of applications, major sectors, deployment models, organization size, and regions. The report contains an analysis of the major factors influencing the growth of the
Incretin-based Drugs Market to Witness an Outstanding Growth by 2025
Incretins are metabolic hormones that are activated when blood glucose levels decrease in the body. Incretin-based drugs are used in the treatment of type 2 diabetes. These drugs are associated with low risk of hypoglycemia and deliver positive effect on body weight. Oral anti-diabetic drugs often fail to maintain the desired glucose levels postprandial. This has increased demand for better and highly efficient therapeutics such as incretin-based drugs. Incretin-based drugs assist
Incretin-based Drugs Market Size, Status and Forecast up to 2025
Incretins are metabolic hormones that are activated when blood glucose levels decrease in the body. Incretin-based drugs are used in the treatment of type 2 diabetes. These drugs are associated with low risk of hypoglycemia and deliver positive effect on body weight. Oral anti-diabetic drugs often fail to maintain the desired glucose levels postprandial. This has increased demand for better and highly efficient therapeutics such as incretin-based drugs. View Report - https://www.transparencymarketresearch.com/incretinbased-drugs-market.html Incretin-based
Incretin based Drugs Market Insights and Analysis for Period 2017 - 2025
Incretins are metabolic hormones that are activated when blood glucose levels decrease in the body. Incretin-based drugs are used in the treatment of type 2 diabetes. These drugs are associated with low risk of hypoglycemia and deliver positive effect on body weight. Oral anti-diabetic drugs often fail to maintain the desired glucose levels postprandial. This has increased demand for better and highly efficient therapeutics such as incretin-based drugs. Incretin-based drugs